HEADER HYDROLASE/HYDROLASE INHIBITOR 01-NOV-99 1DAZ TITLE STRUCTURAL AND KINETIC ANALYSIS OF DRUG RESISTANT MUTANTS OF HIV-1 TITLE 2 PROTEASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIV-1 PROTEASE (RETROPEPSIN); COMPND 3 CHAIN: C, D; COMPND 4 EC: 3.4.23.16; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HIV-1 PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX, REDUCED KEYWDS 2 PEPTIDE INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR B.MAHALINGAM,J.M.LOUIS,C.C.REED,J.M.ADOMAT,J.KROUSE,Y.F.WANG, AUTHOR 2 R.W.HARRISON,I.T.WEBER REVDAT 7 13-MAR-24 1DAZ 1 COMPND SOURCE REVDAT 6 07-FEB-24 1DAZ 1 REMARK REVDAT 5 03-NOV-21 1DAZ 1 REMARK SEQADV SHEET REVDAT 4 13-JUL-11 1DAZ 1 VERSN REVDAT 3 24-FEB-09 1DAZ 1 VERSN REVDAT 2 01-APR-03 1DAZ 1 JRNL REVDAT 1 03-MAY-00 1DAZ 0 JRNL AUTH B.MAHALINGAM,J.M.LOUIS,C.C.REED,J.M.ADOMAT,J.KROUSE, JRNL AUTH 2 Y.F.WANG,R.W.HARRISON,I.T.WEBER JRNL TITL STRUCTURAL AND KINETIC ANALYSIS OF DRUG RESISTANT MUTANTS OF JRNL TITL 2 HIV-1 PROTEASE. JRNL REF EUR.J.BIOCHEM. V. 263 238 1999 JRNL REFN ISSN 0014-2956 JRNL PMID 10429209 JRNL DOI 10.1046/J.1432-1327.1999.00514.X REMARK 2 REMARK 2 RESOLUTION. 1.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.843 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 26752 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE-R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1847 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.55 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.62 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2942 REMARK 3 BIN R VALUE (WORKING SET) : 0.2669 REMARK 3 BIN FREE R VALUE : 0.2838 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 258 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1510 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 59 REMARK 3 SOLVENT ATOMS : 141 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.320 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARHCSDX.PRO REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1DAZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-NOV-99. REMARK 100 THE DEPOSITION ID IS D_1000009935. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-OCT-97 REMARK 200 TEMPERATURE (KELVIN) : 90 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X12B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9803 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27073 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.550 REMARK 200 RESOLUTION RANGE LOW (A) : 32.600 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.05400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.61 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.9 REMARK 200 DATA REDUNDANCY IN SHELL : 5.96 REMARK 200 R MERGE FOR SHELL (I) : 0.13300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.65 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.97 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CITRATE/PHOSPHATE BUFFER 0.05M, DTT REMARK 280 10MM, DMSO 10%, SATURATED AMMONIUM SULPHATE 25-50%, PROTEIN 2-5 REMARK 280 MG/ML, PH 5.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 297K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.61950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 30.60750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.09600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 30.60750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.61950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.09600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 THERE ARE TWO OPPOSITE ORIENTATIONS OF THE PEPTIDE REMARK 600 INHIBITOR 0Q4 WITH HALF OCCUPANCIES EACH. REMARK 600 REMARK 600 THE INHIBITOR HAS A REDUCED PEPTIDE (-CH2-NH) INSTEAD REMARK 600 OF THE NORMAL PEPTIDE LINK (-CO-NH). REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: N-[(2R)-2-({N~5~-[AMINO(IMINIO)METHYL]-L-ORNITHYL-L- REMARK 630 VALYL}AMINO)-4-METHYLPENTYL]-L-PHENYLALANYL-L-ALPHA-GLUTAMYL-L- REMARK 630 ALANYL-L-NORLEUCINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 0Q4 D 601 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: ARG VAL DC0 GLU ALA NLE NH2 REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0Q4 D 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A94 RELATED DB: PDB REMARK 900 1A94 IS THE STRUCTURE OF THE HIV-1 PROTEASE WITH MUTATIONS Q7K, REMARK 900 L33I, L63I, C67A, C95A, WHICH STABILIZE THE PROTEASE FROM REMARK 900 AUTOPROTEOLYSIS, WHILE RETAINING ACTIVITY SIMILAR TO WILD TYPE HIV- REMARK 900 1 PROTEASE. THIS MUTANT (K45I) ALSO HAS THE ABOVE MUTATIONS TO REMARK 900 PREVENT AUTOPROTEOLYSIS. DBREF 1DAZ C 1 99 UNP P03367 POL_HV1BR 500 598 DBREF 1DAZ D 101 199 UNP P03367 POL_HV1BR 500 598 SEQADV 1DAZ LYS C 7 UNP P03367 GLN 75 ENGINEERED MUTATION SEQADV 1DAZ ILE C 33 UNP P03367 LEU 91 ENGINEERED MUTATION SEQADV 1DAZ ILE C 45 UNP P03367 LYS 103 ENGINEERED MUTATION SEQADV 1DAZ ILE C 63 UNP P03367 LEU 131 ENGINEERED MUTATION SEQADV 1DAZ ALA C 67 UNP P03367 CYS 135 ENGINEERED MUTATION SEQADV 1DAZ ALA C 95 UNP P03367 CYS 163 ENGINEERED MUTATION SEQADV 1DAZ LYS D 107 UNP P03367 GLN 75 ENGINEERED MUTATION SEQADV 1DAZ ILE D 133 UNP P03367 LEU 91 ENGINEERED MUTATION SEQADV 1DAZ ILE D 145 UNP P03367 LYS 103 ENGINEERED MUTATION SEQADV 1DAZ ILE D 163 UNP P03367 LEU 131 ENGINEERED MUTATION SEQADV 1DAZ ALA D 167 UNP P03367 CYS 135 ENGINEERED MUTATION SEQADV 1DAZ ALA D 195 UNP P03367 CYS 163 ENGINEERED MUTATION SEQRES 1 C 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 C 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 C 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 C 99 GLY ARG TRP LYS PRO ILE MET ILE GLY GLY ILE GLY GLY SEQRES 5 C 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 C 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 C 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 C 99 GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 D 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 D 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 D 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 D 99 GLY ARG TRP LYS PRO ILE MET ILE GLY GLY ILE GLY GLY SEQRES 5 D 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 D 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 D 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 D 99 GLN ILE GLY ALA THR LEU ASN PHE HET 0Q4 D 601 118 HETNAM 0Q4 N-[(2R)-2-({N~5~-[AMINO(IMINIO)METHYL]-L-ORNITHYL-L- HETNAM 2 0Q4 VALYL}AMINO)-4-METHYLPENTYL]-L-PHENYLALANYL-L-ALPHA- HETNAM 3 0Q4 GLUTAMYL-L-ALANYL-L-NORLEUCINAMIDE HETSYN 0Q4 INHIBITOR ANALOGUES OF CA-P2 FORMUL 3 0Q4 C40 H70 N11 O8 1+ FORMUL 4 HOH *141(H2 O) HELIX 1 1 GLY C 86 THR C 91 1 6 HELIX 2 2 GLY D 186 THR D 191 1 6 SHEET 1 A 4 GLN C 2 ILE C 3 0 SHEET 2 A 4 THR D 196 ASN D 198 -1 O LEU D 197 N ILE C 3 SHEET 3 A 4 THR C 96 ASN C 98 -1 N THR C 96 O ASN D 198 SHEET 4 A 4 GLN D 102 THR D 104 -1 N ILE D 103 O LEU C 97 SHEET 1 B 8 LYS C 43 GLY C 49 0 SHEET 2 B 8 GLY C 52 ILE C 66 -1 O GLY C 52 N GLY C 49 SHEET 3 B 8 HIS C 69 GLY C 78 -1 O HIS C 69 N ILE C 66 SHEET 4 B 8 VAL C 32 GLU C 34 1 N ILE C 33 O LEU C 76 SHEET 5 B 8 ILE C 84 ILE C 85 -1 N ILE C 84 O VAL C 32 SHEET 6 B 8 GLN C 18 LEU C 24 1 O LEU C 23 N ILE C 85 SHEET 7 B 8 LEU C 10 ILE C 15 -1 O VAL C 11 N ALA C 22 SHEET 8 B 8 GLY C 52 ILE C 66 -1 N GLU C 65 O LYS C 14 SHEET 1 C 8 TRP D 142 GLY D 149 0 SHEET 2 C 8 PHE D 153 ILE D 166 -1 N ILE D 154 O ILE D 147 SHEET 3 C 8 HIS D 169 VAL D 177 -1 O HIS D 169 N ILE D 166 SHEET 4 C 8 VAL D 132 ILE D 133 1 N ILE D 133 O LEU D 176 SHEET 5 C 8 ILE D 184 ILE D 185 -1 N ILE D 184 O VAL D 132 SHEET 6 C 8 GLN D 118 LEU D 124 1 O LEU D 123 N ILE D 185 SHEET 7 C 8 LEU D 110 ILE D 115 -1 N VAL D 111 O ALA D 122 SHEET 8 C 8 PHE D 153 ILE D 166 -1 N GLU D 165 O LYS D 114 SITE 1 AC1 41 TRP C 6 ARG C 8 LEU C 23 ASP C 25 SITE 2 AC1 41 GLY C 27 ALA C 28 ASP C 29 ASP C 30 SITE 3 AC1 41 VAL C 32 ILE C 45 MET C 46 ILE C 47 SITE 4 AC1 41 GLY C 48 GLY C 49 ILE C 50 PHE C 53 SITE 5 AC1 41 GLN C 58 PRO C 81 VAL C 82 ILE C 84 SITE 6 AC1 41 HOH D 14 HOH D 49 ARG D 108 LEU D 123 SITE 7 AC1 41 ASP D 125 GLY D 127 ASP D 129 ASP D 130 SITE 8 AC1 41 VAL D 132 MET D 146 ILE D 147 GLY D 148 SITE 9 AC1 41 GLY D 149 ILE D 150 PRO D 181 VAL D 182 SITE 10 AC1 41 ILE D 184 HOH D 261 HOH D 262 HOH D 263 SITE 11 AC1 41 HOH D 387 CRYST1 51.239 58.192 61.215 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019516 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017184 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016336 0.00000